betulinic acid and osteoprotegerin

betulinic acid has been researched along with osteoprotegerin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chung, WY; Kim, HJ; Kim, KR; Lee, CK; Lee, SK; Park, KK; Park, SY	1

Other Studies

1 other study(ies) available for betulinic acid and osteoprotegerin

Article	Year
Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment. Toxicology and applied pharmacology, 2014, Mar-01, Volume: 275, Issue:2 Topics: Administration, Oral; Animals; Betulinic Acid; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Cathepsin K; Cell Differentiation; Cell Line, Tumor; Cell Survival; Down-Regulation; Estrogens; Female; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred ICR; Osteoclasts; Osteoprotegerin; Parathyroid Hormone-Related Protein; Pentacyclic Triterpenes; RANK Ligand; Triterpenes	2014

Article

Year

Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment.

Toxicology and applied pharmacology, 2014, Mar-01, Volume: 275, Issue:2

Topics: Administration, Oral; Animals; Betulinic Acid; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Cathepsin K; Cell Differentiation; Cell Line, Tumor; Cell Survival; Down-Regulation; Estrogens; Female; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred ICR; Osteoclasts; Osteoprotegerin; Parathyroid Hormone-Related Protein; Pentacyclic Triterpenes; RANK Ligand; Triterpenes

2014